Mitral Regurgitation - Valvular Heart Disease Guidelines

Valvular Heart Disease

ACC/AHA Valvular Heart Disease - Mitral Regurgitation GUIDELINES Apps brought to you charge courtesy of Guideline Central and Abbott Vascular.

Issue link: https://eguideline.guidelinecentral.com/i/362036

Contents of this Issue

Navigation

Page 45 of 59

44 Infectious Endocarditis Table 31A. Prophylaxis of IE Recommendations COR LOE Prophylaxis Prophylaxis against IE is reasonable for the following patients at highest risk for adverse outcomes from IE before dental procedures that involve manipulation of gingival tissue, manipulation of the periapical region of teeth, or perforation of the oral mucosa: • Patients with prosthetic cardiac valves; • Patients with previous IE; • Cardiac transplant recipients with valve regurgitation due to a structurally abnormal valve; or • Patients with congenital heart disease: > Unrepaired cyanotic congenital heart disease, including palliative shunts and conduits; > Completely repaired congenital heart defect repaired with prosthetic material or device, whether placed by surgery or catheter intervention, during the first 6 months after the procedure; > Repaired congenital heart disease with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device. IIa B Prophylaxis against IE is NOT recommended in patients with VHD who are at risk of IE for nondental procedures (eg, TEE, esophagogastroduodenoscopy, colonoscopy, or cystoscopy) in the absence of active infection. III: No Benefit B Table 31B. Diagnosis and Treatment of IE Recommendations COR LOE Diagnosis At least 2 sets of blood cultures should be obtained in patients at risk for IE (eg, those with congenital or acquired VHD, previous IE, prosthetic heart valves, certain congenital or heritable heart malformations, immunodeficiency states, or injection drug users) who have unexplained fever for more than 48 hours I B or patients with newly diagnosed le-sided valve regurgitation. I C e Modified Duke Criteria should be used in evaluating a patient with suspected IE (Tables 32-33). I B Cardiac CT is reasonable to evaluate morpholog y/anatomy in the setting of suspected paravalvular infections when the anatomy cannot be clearly delineated by echocardiography. IIa B TEE & TTE TTE is recommended in patients with suspected IE to identify vegetations, characterize the hemodynamic severity of valvular lesions, assess ventricular function and pulmonary pressures, and detect complications. I B

Articles in this issue

view archives of Mitral Regurgitation - Valvular Heart Disease Guidelines - Valvular Heart Disease